Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,937 | 1,307 | 99.5% |
| Education | $96.57 | 9 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,044 | 161 | $0 (2024) |
| ABBVIE INC. | $1,799 | 123 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,585 | 155 | $0 (2024) |
| Lilly USA, LLC | $1,473 | 94 | $0 (2024) |
| PFIZER INC. | $1,268 | 133 | $0 (2024) |
| Amgen Inc. | $1,215 | 79 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,027 | 56 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $822.52 | 54 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $662.86 | 61 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $474.78 | 32 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,434 | 87 | Lilly USA, LLC ($221.18) |
| 2023 | $3,264 | 201 | AbbVie Inc. ($427.17) |
| 2022 | $3,623 | 247 | ABBVIE INC. ($470.50) |
| 2021 | $3,528 | 250 | AbbVie Inc. ($605.14) |
| 2020 | $1,713 | 126 | Novo Nordisk Inc ($308.18) |
| 2019 | $1,483 | 126 | PFIZER INC. ($258.48) |
| 2018 | $1,470 | 124 | AstraZeneca Pharmaceuticals LP ($196.93) |
| 2017 | $1,518 | 155 | Allergan Inc. ($189.55) |
All Payment Transactions
1,316 individual payment records from CMS Open Payments — Page 1 of 53
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: Gastroenterology | ||||||
| 07/17/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Gastroenterology | ||||||
| 07/02/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Gastroenterology | ||||||
| 06/28/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: RESPIRATORY | ||||||
| 06/28/2024 | CeQur Corporation | CeQur Simplicity (Device) | Food and Beverage | Cash or cash equivalent | $16.53 | General |
| Category: Diabetes | ||||||
| 06/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, SYNJARDY | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: DIABETES | ||||||
| 06/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: Diabetes | ||||||
| 06/17/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: Endocrinology | ||||||
| 06/14/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: Obesity | ||||||
| 06/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $0.51 | General |
| Category: RESPIRATORY | ||||||
| 06/10/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Cardiology | ||||||
| 06/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $9.51 | General |
| Category: RESPIRATORY | ||||||
| 06/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Obesity | ||||||
| 06/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Gastroenterology | ||||||
| 06/03/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Gastroenterology | ||||||
| 05/30/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Gastroenterology | ||||||
| 05/30/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Gastroenterology | ||||||
| 05/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Diabetes | ||||||
| 05/24/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Bone Health | ||||||
| 05/23/2024 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Genetic Disease | ||||||
| 05/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: NEUROSCIENCE | ||||||
| 05/20/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $23.05 | General |
| Category: Cardiovascular | ||||||
| 05/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $0.59 | General |
| Category: RESPIRATORY | ||||||
| 05/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,173 | 1,696 | $212,930 | $121,516 |
| 2022 | 14 | 1,310 | 1,993 | $242,375 | $140,582 |
| 2021 | 16 | 1,342 | 2,085 | $253,945 | $147,867 |
| 2020 | 16 | 1,382 | 2,071 | $234,570 | $124,301 |
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 424 | 733 | $109,950 | $60,182 | 54.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 270 | 404 | $40,400 | $20,405 | 50.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 100 | 124 | $22,940 | $15,580 | 67.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 100 | 102 | $8,670 | $7,327 | 84.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 18 | 18 | $7,650 | $5,068 | 66.2% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 16 | 67 | $6,700 | $3,754 | 56.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 107 | 109 | $4,360 | $3,210 | 73.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 21 | 21 | $4,130 | $2,586 | 62.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 12 | 12 | $2,760 | $1,893 | 68.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 17 | 17 | $680.00 | $500.65 | 73.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 16 | $1,200 | $490.83 | 40.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 46 | 46 | $3,220 | $427.05 | 13.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 26 | 27 | $270.00 | $92.07 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 443 | 862 | $129,300 | $69,529 | 53.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 311 | 491 | $49,100 | $29,074 | 59.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 115 | 139 | $25,715 | $17,758 | 69.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 111 | 111 | $9,435 | $7,608 | 80.6% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 21 | 72 | $6,480 | $3,753 | 57.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 121 | 121 | $4,840 | $3,423 | 70.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 11 | 11 | $4,675 | $3,059 | 65.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 14 | 14 | $2,730 | $1,772 | 64.9% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 13 | 13 | $2,105 | $1,715 | 81.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 31 | 31 | $2,325 | $1,205 | 51.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 27 | 27 | $960.00 | $767.60 | 80.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 54 | 58 | $4,060 | $588.37 | 14.5% |
About Dr. Eric Binder, M.D
Dr. Eric Binder, M.D is a Internal Medicine healthcare provider based in Camp Hill, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1437149341.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Binder, M.D has received a total of $18,034 in payments from pharmaceutical and medical device companies, with $1,434 received in 2024. These payments were reported across 1,316 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($17,937).
As a Medicare-enrolled provider, Binder has provided services to 5,207 Medicare beneficiaries, totaling 7,845 services with total Medicare billing of $534,266. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Camp Hill, PA
- Active Since 10/24/2005
- Last Updated 10/19/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1437149341
Products in Payments
- Ozempic (Drug) $902.68
- TRELEGY ELLIPTA (Drug) $882.84
- XIFAXAN (Drug) $838.34
- ELIQUIS (Drug) $587.00
- FARXIGA (Drug) $575.57
- QULIPTA (Drug) $570.21
- EVENITY (Biological) $556.68
- TRULICITY (Drug) $542.40
- NURTEC ODT (Drug) $502.19
- VRAYLAR (Drug) $486.53
- MOUNJARO (Drug) $483.95
- XARELTO (Drug) $466.02
- ENTRESTO (Drug) $439.13
- Vascepa (Drug) $420.10
- Rybelsus (Drug) $399.99
- UBRELVY (Drug) $329.08
- JARDIANCE (Drug) $310.64
- TRADJENTA (Drug) $292.35
- LINZESS (Drug) $286.79
- Aimovig (Biological) $283.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Camp Hill
Rena Dearment, Md, MD
Internal Medicine — Payments: $290,160
Nayanjyoti Kaushik, M.d, M.D
Internal Medicine — Payments: $57,720
Greg Ehgartner, D.o, D.O
Internal Medicine — Payments: $17,256
Stephanie Madonis
Internal Medicine — Payments: $13,739
Harinidevi Krishnan, M.d, M.D
Internal Medicine — Payments: $12,862
Namrata Haldipur, M.d, M.D
Internal Medicine — Payments: $12,697